FDA approves new HIV treatment

Posted by Food and Drug Administration--Press Releases on Friday May 20, 2011 Under News

The U.S. Food and Drug Administration today approved Edurant (rilpivirine) in combination with other antiretroviral drugs for the treatment of HIV-1 infection in adults who have never taken HIV therapy (treatment-naïve).

Be Sociable, Share!

Comments are closed.